BACKGROUND: In 1995 the Tucson Children's Respiratory Study (TCRS) identified clinically distinct phenotypes amongst early wheezers; the Avon Longitudinal Study of Parents And Children (ALSPAC) has recently re-examined these. OBJECTIVES: To validate statistically derived ALSPAC phenotypes in the Southampton Women's Survey (SWS) using infant and 6-year lung function, and allergic sensitization at 1, 3, and 6 years, comparing these with TCRS phenotypes. METHODS: Complete 6-year follow-up data were available for 926 children, selected from 1,973 infants born to 12,579 women characterized pre-conception. Ninety-five children had V'maxFRC and FEV0.4 measured age 5-14 weeks using rapid compression/raised volume techniques. At 6 years we performed spirometry (n = 791), fractional exhaled nitric oxide (FeNO, n = 589) and methacholine challenge (n = 234). Skin prick testing was performed at 12m, 3 and 6 years (n = 1,494, 1,255, 699, respectively). Using wheeze status questionnaire data at 6m, 12m, 2, 3 and 6 years we classified children into TCRS (never, transient early, persistent, late-onset) and ALSPAC based groups (never, early, transient, intermediate-onset, late-onset, persistent). RESULTS: Amongst ALSPAC groups, persistent and late-onset wheeze were associated with atopy at 3 and 6 years, whilst intermediate-onset wheeze showed earlier atopic association at 1 year; all three were associated with FeNO at 6 years. Persistent wheezers had lower infant (V'maxFRC P < 0.05) and 6-year lung function (FEV1, FEV1/FVC, and FEF(25-75), P < 0.05), whilst late and intermediate-onset wheezers showed no lung function deficits. Transient wheezers were non-atopic but showed persistent lung function deficits (V'maxFRC in infancy, FEV1 and FEF(25-75) at 6 years, all P < 0.05). Those who wheezed only in the first year (early phenotype) showed no lung function deficits. No associations were seen with 6 years bronchial hyper-responsiveness or infancy FEV0.4. CONCLUSION: SWS cohort data validates the statistically derived ALSPAC six-class model. In particular, lung function and atopy successfully differentiate persistent, late-onset and intermediate-onset wheeze, whilst the Tucson "transient early" wheeze phenotype can be sub-classified into groups that reflect early lung function. Since the 4-class model fails to adequately differentiate phenotypes based on lung function and atopy, we propose that strong consideration be given to using the 6-class paradigm for longitudinal outcome work in wheezing with onset in early life.
BACKGROUND: In 1995 the Tucson Children's Respiratory Study (TCRS) identified clinically distinct phenotypes amongst early wheezers; the Avon Longitudinal Study of Parents And Children (ALSPAC) has recently re-examined these. OBJECTIVES: To validate statistically derived ALSPAC phenotypes in the Southampton Women's Survey (SWS) using infant and 6-year lung function, and allergic sensitization at 1, 3, and 6 years, comparing these with TCRS phenotypes. METHODS: Complete 6-year follow-up data were available for 926 children, selected from 1,973 infants born to 12,579 women characterized pre-conception. Ninety-five children had V'maxFRC and FEV0.4 measured age 5-14 weeks using rapid compression/raised volume techniques. At 6 years we performed spirometry (n = 791), fractional exhaled nitric oxide (FeNO, n = 589) and methacholine challenge (n = 234). Skin prick testing was performed at 12m, 3 and 6 years (n = 1,494, 1,255, 699, respectively). Using wheeze status questionnaire data at 6m, 12m, 2, 3 and 6 years we classified children into TCRS (never, transient early, persistent, late-onset) and ALSPAC based groups (never, early, transient, intermediate-onset, late-onset, persistent). RESULTS: Amongst ALSPAC groups, persistent and late-onset wheeze were associated with atopy at 3 and 6 years, whilst intermediate-onset wheeze showed earlier atopic association at 1 year; all three were associated with FeNO at 6 years. Persistent wheezers had lower infant (V'maxFRC P < 0.05) and 6-year lung function (FEV1, FEV1/FVC, and FEF(25-75), P < 0.05), whilst late and intermediate-onset wheezers showed no lung function deficits. Transient wheezers were non-atopic but showed persistent lung function deficits (V'maxFRC in infancy, FEV1 and FEF(25-75) at 6 years, all P < 0.05). Those who wheezed only in the first year (early phenotype) showed no lung function deficits. No associations were seen with 6 years bronchial hyper-responsiveness or infancy FEV0.4. CONCLUSION: SWS cohort data validates the statistically derived ALSPAC six-class model. In particular, lung function and atopy successfully differentiate persistent, late-onset and intermediate-onset wheeze, whilst the Tucson "transient early" wheeze phenotype can be sub-classified into groups that reflect early lung function. Since the 4-class model fails to adequately differentiate phenotypes based on lung function and atopy, we propose that strong consideration be given to using the 6-class paradigm for longitudinal outcome work in wheezing with onset in early life.
Authors: Jessica E Brussee; Henriette A Smit; Robert T van Strien; Karen Corver; Marjan Kerkhof; Alet H Wijga; Rob C Aalberse; Dirkje Postma; Jorrit Gerritsen; Diederick E Grobbee; Johan C de Jongste; Bert Brunekreef Journal: J Allergy Clin Immunol Date: 2005-05 Impact factor: 10.793
Authors: Angela Simpson; Nikolas Maniatis; Francine Jury; Julie A Cakebread; Lesley A Lowe; Stephen T Holgate; Ashley Woodcock; William E R Ollier; Andrew Collins; Adnan Custovic; John W Holloway; Sally L John Journal: Am J Respir Crit Care Med Date: 2005-04-01 Impact factor: 21.405
Authors: E Melén; S Umerkajeff; F Nyberg; M Zucchelli; A Lindstedt; H Gullstén; M Wickman; G Pershagen; J Kere Journal: Clin Exp Allergy Date: 2006-11 Impact factor: 5.018
Authors: Jane S Lucas; Hazel M Inskip; Keith M Godfrey; Claire T Foreman; John O Warner; Rachael K Gregson; Joanne B Clough Journal: Am J Respir Crit Care Med Date: 2004-06-01 Impact factor: 21.405
Authors: Katharine C Pike; Sarah R Crozier; Jane S A Lucas; Hazel M Inskip; Sian Robinson; Graham Roberts; Keith M Godfrey Journal: Thorax Date: 2010-10-18 Impact factor: 9.139
Authors: Olga E Savenije; Raquel Granell; Daan Caudri; Gerard H Koppelman; Henriëtte A Smit; Alet Wijga; Johan C de Jongste; Bert Brunekreef; Jonathan A Sterne; Dirkje S Postma; John Henderson; Marjan Kerkhof Journal: J Allergy Clin Immunol Date: 2011-03-16 Impact factor: 10.793
Authors: Hazel M Inskip; Keith M Godfrey; Siân M Robinson; Catherine M Law; David J P Barker; Cyrus Cooper Journal: Int J Epidemiol Date: 2005-09-29 Impact factor: 7.196
Authors: Alireza Sadeghnejad; Wilfried Karmaus; S Hasan Arshad; Ramesh Kurukulaaratchy; Marianne Huebner; Susan Ewart Journal: Respir Res Date: 2008-01-10
Authors: Christine Cole Johnson; Edward L Peterson; Christine L M Joseph; Dennis R Ownby; Naomi Breslau Journal: J Asthma Date: 2015-09-16 Impact factor: 2.515
Authors: Edward Zoratti; Suzanne Havstad; Ganesa Wegienka; Charlotte Nicholas; Kevin R Bobbitt; Kimberley J Woodcroft; Dennis R Ownby; Christine Cole Johnson Journal: Ann Allergy Asthma Immunol Date: 2014-05-05 Impact factor: 6.347
Authors: Marketa Vrbova; Petra Dorociakova; Roman Vyskovsky; Lubica Palkovicova Murinova; Peter Ciznar; Katarina Rausova; Scott J N McNabb; Eva Reichrtova; Eva Budinska; Vojtech Thon Journal: Eur J Pediatr Date: 2018-06-22 Impact factor: 3.183